Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients

Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients

BackgroundExisting evidence on the associations of liver steatosis and fibrosis with bone mineral density (BMD) and risk of osteopenia/osteoporosis was limited with conflicting results. We aimed to evaluate the associations of metabolic dysfunction-associated fatty liver disease (MAFLD) and hepatic...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Yuhua Li, Shangjian Li, Jingqi Zhou, Kai Wang, Zhibin Li, Ning Chen, Xueqin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Endocrinology
Subjects:
osteoporosis
osteopenia
diabetes
MAFLD
hepatic steatosis
hepatic fibrosis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1278505/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1278505/full

Similar Items